GVK Davix Technologies

Hyderabad, India Founded: 2001 • Age: 25 yrs
Provider of drug preclinical and formulation development services

About GVK Davix Technologies

GVK Davix Technologies is a Healthcare company based in Hyderabad (India) founded in 2001. Provider of drug preclinical and formulation development services. It operates on a Biopharma Outsourcing model. The company has 3,859 employees. Its chief executive, as recorded, is Manni Kantipudi. Its Indian entity Aragen Life Sciences Limited reported revenue of β‚Ή1,870 Cr. GVK Davix Technologies offers products and services including GVK Davix Technologies Platform. Its focus areas include Life Sciences and Biopharma Outsourcing.

Company details

GVK Davix Technologies, led by Manni Kantipudi as CEO, specializes in life sciences, biopharma outsourcing, biopharma outsourcing, and providing healthcare solutions. Provider of drug preclinical and formulation development services. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.

  • Headquarters Hyderabad, India
  • Employees 3,859
  • Sectors
    Healthcare
  • Website gvkbio.com
  • Legal Name Aragen Life Sciences Limited
  • Date of Incorporation 07 Dec, 2000
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹1,870 Cr

    FY 2025 · +12% YoY

  • Net Profit
    ₹180 Cr

    FY 2025 · 10% margin

  • EBITDA
    ₹478 Cr

    FY 2025 · 26% margin

  • Employee Count
    3,859

Products & Services of GVK Davix Technologies

GVK Davix Technologies offers a comprehensive portfolio of products and services, including GVK Davix Technologies Platform.

GVK Davix Technologies Platform
Life Sciences

Provider of drug preclinical and formulation development services

Board of directors of Aragen Life Sciences Limited (GVK Davix Technologies)

Aragen Life Sciences Limited is the primary company behind GVK Davix Technologies. The board of Aragen Life Sciences Limited currently have 9 directors; the longest-serving is Davinder Singh Brar, appointed in 2004. 19 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Davinder Singh Brar
DIN 00068502
Director26 Jul 200422 yrs 3 moAragen Life Sciences Limited
Manmahesh Kantipudi
DIN 05241166
Managing Director29 May 20188 yrs 5 moAragen Life Sciences Limited
Robert Richard Ruffolo
DIN 08404004
Director17 Apr 20197 yrs 6 moAragen Life Sciences Limited
Gunapati Reddy Venkat Keshav
DIN 06593325
Director30 Jan 20206 yrs 9 moAragen Life Sciences Limited
Rajat Sood
DIN 07914803
Director19 May 20215 yrs 5 moAragen Life Sciences Limited
Ajay Srivastava
DIN 00049912
Director20 May 20215 yrs 5 moAragen Life Sciences Limited
Anita Ramachandran
DIN 00118188
Director07 Nov 20224 yrsAragen Life Sciences Limited
Sachin Anand Dharap
DIN 00785700
CFO25 Jan 20233 yrs 9 moAragen Life Sciences Limited
Amit Varma
DIN 02241746
Director09 Jan 20251 yr 9 moAragen Life Sciences Limited

People of GVK Davix Technologies

14 people are tracked at GVK Davix Technologies (2 in leadership, 8 in board & advisors, 4 in team); the tracked headcount is 3,859.

NameRoleGroup
Manni Kantipudi
CEOLeadership
Sudhir Kumar Singh
Executive Vice President, Discovery ServicesLeadership
DirectorBoard & advisors
Sanjiv Dwarkanath Kaul
DirectorBoard & advisors
Gunupati Indira Krishna Reddy
DirectorBoard & advisors
Sanjay Reddy
Vice ChairmanBoard & advisors
DirectorBoard & advisors
Gerhard Mayr
DirectorBoard & advisors
Sahajbir Singh Brar
DirectorBoard & advisors
ChairmanBoard & advisors
Vamshi Krishna Baloju
Research AssociateTeam
Dr Vasu Babu Gorantla
Scientific ManagerTeam
Ramakrishna Reddy
PharmaTeam
Santhosh Reddy Jangari
ScientistTeam
Premium access

Complete people profiles for GVK Davix Technologies

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of GVK Davix Technologies

Figures of Aragen Life Sciences Limited, the primary company behind GVK Davix Technologies, for FY 2025. Revenue was ₹1,870 Cr (+12% year on year). Net profit was ₹180 Cr (10% margin). EBITDA was ₹478 Cr (26% margin). Revenue has grown at a compounded annual rate of +10% over three years and +14% over five years.

  • ₹1,870 CrRevenue · FY 2025 · +12% YoY
  • ₹180 CrNet profit · 10% margin
  • ₹478 CrEBITDA · 26% margin
  • ₹217 CrPaid-up capital
  • 3,859Employees (provident fund records)
  • +10%Revenue CAGR, 3 years
  • +14%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Aragen Life Sciences Limited are on its company page.

Premium access

Detailed financial statements for GVK Davix Technologies

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of GVK Davix Technologies

Websites that share an audience with GVK Davix Technologies (gvkbio.com).

Similar websites

Websites whose visitors overlap most with GVK Davix Technologies. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
lambda-cro.com
100%
38.8K#490,207View details
lotuslabs.com
lotuslabs.com
99%
#9,992,804–
jrfonline.com
jrfonline.com
92%
–
ppccro.com
90%
View details
ipcalabs.com
90%
#6,089,785View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 13 similar websites and full traffic analytics for GVK Davix Technologies

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 13 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as GVK Davix Technologies (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Gvk Davix Technologies

Premium access

Complete news archive for GVK Davix Technologies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about GVK Davix Technologies

GVK Davix Technologies was founded in 2001.

GVK Davix Technologies is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Manni Kantipudi is the CEO of GVK Davix Technologies, as recorded in our data.

GVK Davix Technologies has 3,859 employees.

The primary company behind GVK Davix Technologies, Aragen Life Sciences Limited, reported revenue of β‚Ή1,870 Cr for FY 2025, up 12% year on year.

GVK Davix Technologies, led by Manni Kantipudi as CEO, specializes in life sciences, biopharma outsourcing, biopharma outsourcing, and providing healthcare solutions. Provider of drug preclinical and formulation development services. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.

GVK Davix Technologies offers GVK Davix Technologies Platform.

GVK Davix Technologies operates through Aragen Life Sciences Limited.

The legal entities of GVK Davix Technologies currently have 10 directors, including Davinder Singh Brar, Amit Varma, Ajay Srivastava and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available